Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05839652 · ClinicalTrials.gov registry record · Phase 4
Treatment of Orthostatic Hypotension in SCI
A Phase 4 study of Hypotension, sponsored by James J. Peters Veterans Affairs Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
- 2
- Study locations
NCT05839652: Recruiting Phase 4 study of Hypotension, sponsored by James J. Peters Veterans Affairs Medical Center.
NCT05839652 is a Phase 4 study of Hypotension that is actively recruiting participants, run by James J. Peters Veterans Affairs Medical Center. The registered enrollment target is 25 participants, below the 78-participant average among 12 other Hypotension trials with a reported enrollment target (68% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05839652, a Phase 4 study of Hypotension, is actively recruiting participants, sponsored by James J. Peters Veterans Affairs Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to identify the effects of non-pharmacological and pharmacological anti-hypotensive treatment interventions on orthostatic hemodynamic responses, symptoms of autonomic dysreflexia and orthostatic hypotension, and levels of fatigue and comfort in hypotensive individuals with SCI.
Primary Outcome
determine differences in systolic blood pressure after midodrine, droxidopa, compression stockings and placebo
Conditions Studied
Interventions
- DRUG Midodrine Hydrochloride
Study Locations (2)
New Jersey
- Kessler Foundation - West Orange
New York
- James J Peters VA Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-07-01 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 4 |
What NCT05839652 shows while recruiting
NCT05839652 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 78-participant average among 12 other Hypotension trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Hypotension appearing as the primary indexed condition, and to 1 intervention - of which Midodrine Hydrochloride is the first listed.
NCT05839652 reports a single indexed study location in New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT05839652 about?
NCT05839652 is a clinical study titled "Treatment of Orthostatic Hypotension in SCI". The purpose of this study is to identify the effects of non-pharmacological and pharmacological anti-hypotensive treatment interventions on orthostatic hemodynamic responses, symptoms of autonomic dysreflexia and orthostatic hypotension, and levels of fatigue and comfort in hypotensive individuals w...
What is the current status of trial NCT05839652?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2023-07-01. Estimated completion is 2026-06-30.
What conditions does trial NCT05839652 study?
This clinical trial studies the following conditions: Hypotension.
What interventions are being tested in trial NCT05839652?
The interventions under investigation include: Midodrine Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT05839652?
This trial is sponsored by James J. Peters Veterans Affairs Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05839652 being conducted?
This trial has 2 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypotension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05839652's enrollment target sits among peer trials
25 11th of 12 higher than 2 of 12 other Hypotension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypotension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV
RECRUITING · Phase 4
-
Evaluating Fluid Strategies in Thoracic Surgery Patients Utilizing a Goal Directed Approach
COMPLETED · Phase 4
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
-
Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)
RECRUITING · NA
-
TSCS for Acute SCI
RECRUITING · NA
-
Noninvasive Continuous BP Monitoring in Newborns Based on Pulsatile Signal Morphological Features Using NIRS
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI